Search results
Results from the WOW.Com Content Network
Common side effects include bleeding and nausea. [8] [9] Other side effects may include bleeding around the spine and allergic reactions. [8] Use is not recommended during pregnancy or breastfeeding. [1] [9] Use appears to be relatively safe in those with mild kidney problems. [9] Compared to warfarin it has fewer interactions with other ...
Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain . [ 2 ]
Warnings - covers possible serious side effects that may occur (e.g., boxed warning) Precautions - explains how to use the medication safely including physical impairments, food ( grapefruits ) and drug interactions; for example "Do not drink alcohol while taking this medication" or "Do not take this medication if you are currently taking MAOI ...
A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's what a doctor wants you to know.
They also found, however, that GLP-1 drugs were linked to several adverse side effects. Novo Nordisk is the maker of Ozempic, which is approved for type 2 diabetes treatment and reduced risk of ...
The most common side effects of Journavx, according to the company’s website, include itching, muscle spasms, rash, and increased levels of an enzyme called creatine phosphokinase in the blood ...
Heparin targets multiple factors in the blood coagulation cascade, one of them being FXa. At first, it had many side effects but for the next twenty years, investigators worked on heparin to make it better and safer. It entered clinical trials in 1935 and the first drug was launched in 1936. Chains of natural heparin can vary from 5.000 to 40. ...
Common side effects include pneumonia and urinary tract infections. [9] Severe side effects may include blood clots, heart attacks, strokes, or cardiac arrest. [9] It works by binding to rivaroxaban and apixaban. [9] It was approved for medical use in the United States in May 2018. [8] It was developed by Portola Pharmaceuticals. [10]